Novel roles in human MD-2 of phenylalanines 121 and 126 and tyrosine 131 in activation of toll-like receptor 4 by endotoxin

Potent mammalian cell activation by Gram-negative bacterial endotoxin requires sequential protein-endotoxin and protein-protein interactions involving lipopolysaccharide-binding protein, CD14, MD-2, and Toll-like receptor 4 (TLR4). TLR4 activation requires simultaneous binding of MD-2 to endotoxin ( E) and the ectodomain of TLR4. We now describe mutants of recombinant human MD-2 that bind TLR4 and react with E center dot CD14 but do not support cellular responsiveness to endotoxin. The mutants F121A/K122A MD-2 and Y131A/K132A MD-2 react with E center dot CD14 only when co-expressed with TLR4. Single mutants K122A and K132A each react with E center dot CD14 +/- TLR4 and promote TLR4-dependent cell activation by endotoxin suggesting that Phe(121) and Tyr(131) are needed for TLR4-independent transfer of endotoxin from CD14 to MD-2 and also needed for TLR4 activation by bound E center dot MD-2. The mutant F126A MD-2 reacts as well as wild-type MD-2 with E center dot CD14 +/- TLR4. E center dot MD-2(F126A) binds TLR4 with high affinity (K-d similar to 200 pM) but does not activate TLR4 and instead acts as a potent TLR4 antagonist, inhibiting activation of HEK/TLR4 cells by wildtype E center dot MD-2. These findings reveal roles of Phe121 and Tyr131 in TLR4-independent interactions of human MD-2 with E center dot CD14 and, together with Phe(126), in activation of TLR4 by bound E center dot MD-2. These findings strongly suggest that the structural properties of E center dot MD-2, not E alone, determine agonist or antagonist effects on TLR4.